NOXXON Pharma N.V. Company Profile

18:58 EDT 19th September 2019 | BioPortfolio

NOXXON’s oncology-focused pipeline acts on the tumor microenvironment (TME) and the cancer immunity cycle by breaking the tumor protection barrier and blocking tumor repair. By neutralizing chemokines in the tumor microenvironment, NOXXON’s approach works in combination with other forms of treatment to weaken tumor defenses against the immune system and enable greater therapeutic impact. Building on extensive clinical experience and safety data, the lead program NOX-A12 has delivered top-line data from a Keytruda® combination trial in metastatic colorectal and pancreatic cancer patients in December 2018 and further studies are being planned in these indications. The company initiated preparations for an additional trial with NOX-A12 in brain cancer in combination with radiotherapy. The combination of NOX-A12 and radiotherapy has been granted orphan drug status in the US and EU for the treatment of certain brain cancers. The company’s second clinical-stage asset NOX-E36 is a Phase 2 TME asset targeting the innate immune system. NOXXON plans to test NOX‑E36 in patients with solid tumors both as a monotherapy and in combination. Further information can be found at:

News Articles [1069 Associated News Articles listed on BioPortfolio]

Original-Research: NOXXON Pharma N.V. (von GBC AG): Vorstandsinterview

Original-Research: NOXXON Pharma N.V. - von GBC AG Einstufung von GBC AG zu NOXXON Pharma N.V. Unternehmen: NOXXON Pharma N.V. ISIN: NL0012044762 Anlass der Studie: GBC-Vorstandsinterview Empfehlu...

NOXXON Pharma: Ordentliche Hauptversammlung nimmt alle Beschlussvorlagen der Tagesordnung an

Bad Marienberg ( - NOXXON Pharma N.V. (ISIN NL0012044762/ WKN A2ASSB) (Euronext Growth Paris: ALNOX), ein Biotechnologieunternehmen mit Fokus auf der Verbesserung von Krebsther...

NOXXON Pharma N.V. Reports 2018 Financial Results

Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today its financial resul...

Aram Mangasarian explains the elegant mirror image technology of NOXXON Pharma for extracellular targets

In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Aram Mangasarian, CBO of NOXXON Pharma AG.


NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), ein Biotechnologieunternehmen mit Fokus auf der Verbesserung von Krebstherapien durch eine gezielte Einwirkung auf die Tumormikroumgebung (TME), ...

Evotec SE, Medigene AG, NOXXON Pharma N.V. - wo lohnt sich jetzt der Einstieg?

Die börsennotierten Biotechnologie Unternehmen Evotec SE, Medigene AG und NOXXON Pharma N.V. beschäftigen sich mit der Bekämpfung von Krebs durch unterschiedliche Therapiearten. Die Unternehmen unt...

NOXXON, Wirecard, Zalando - lohnt sich jetzt der Einstieg?

Am heutigen Handelstag haben die Aktien des Biotechnologie Unternehmens NOXXON Pharma und des Zahlungsverkehrsexperten Wirecard aufgrund ihrer Meldungen ausreichend Gründe, um die Aufmerksamkeit vo.....

Noxxon Aktie mit Kursrallye: Neuer Rechte-Deal winkt

Noxxon Pharma meldet eine Zusammenarbeit bei dem Medikamentenkandidaten NOX-A12. Der Wirkstoff solle in einem neuen Indikationsgebiet getestet werden, heißt es. Man habe eine entsprechende Vereinba.....

Drugs and Medications [53 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]


Ribavirin [aurobindo pharma limited]


PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

The Art of Virtualizing Pharma R&D.

Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.

Although physicians occupy a significant number of key positions in the pharmaceutical industry, practicing clinicians are often unaware of the variety of career paths within this industry, or of the ...

Establishing and Maintaining a Robust Sample Management System.

This paper has been written by the SLAS Sample Management Special Interest Group to serve as a guide to the best practices and methods in establishing and maintaining a high-quality sample management ...

Potential effects of increased openness in pharma: the original knowledge behind new drugs.

This study seeks to determine potential changes in the degree of openness in pharmaceutical R&D by investigating where the knowledge behind new molecular entities (NMEs) comes from in terms of type of...

Clinical Trials [93 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [824 Associated Companies listed on BioPortfolio]


Berlin-based NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers® for the treatment of inflammatory diseases and hematological...

NOXXON Pharma N.V.

NOXXON’s oncology-focused pipeline acts on the tumor microenvironment (TME) and the cancer immunity cycle by breaking the tumor protection barrier and blocking tumor repair. By neutralizing chem...

Noxxon Global Service Informática Ltda


H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "NOXXON Pharma N.V." on BioPortfolio

We have published hundreds of NOXXON Pharma N.V. news stories on BioPortfolio along with dozens of NOXXON Pharma N.V. Clinical Trials and PubMed Articles about NOXXON Pharma N.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NOXXON Pharma N.V. Companies in our database. You can also find out about relevant NOXXON Pharma N.V. Drugs and Medications on this site too.

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Corporate Database Quicklinks

Searches Linking to this Company Record